Search arXivSearch

arXiv subjects

Haoyuan Shi

Publications and source records attributed to Haoyuan Shi.

3 recordsLinked to original sources

DramaChain Bench: An End-to-End Benchmark for Short-Drama Generation

Commercial short-drama production follows a multi-stage chain: script, storyboard, keyframe imagery, shot-level video, and the finished short drama. Most existing benchmarks evaluate solely the video-generation stage using pre-authored inputs instead of real upstream pipeline outputs. This leaves two critical questions unanswerable: whether each stage adheres to the original script intent (rather than only its immediate input prompt), and whether disparate shots remain coherent after assembly into multi-episode releases. We present DramaChain Bench, the first short-drama benchmark that evaluates every stage of the complete production chain. It is built upon three in-house systems sharing one dimension system, DramaChain Dimensions: five evaluation axes instantiated at every stage, resolving into 63 leaf dimensions. DramaChain Agent is calibrated against commercial short-drama platforms in both workflow and finished short-drama quality, enabling stage-wise fair comparison across models. DramaChain Labeling System has each of the 5,785 items scored independently by three professional annotators, with all defects spatio-temporally localised and selected from a predefined defect list. This process produces 17,488 valid scores and 255,925 traceable attribution records. The human annotations confirm that upstream defects cascade across the pipeline, demonstrating that final episode quality is not governed by video generation alone. DramaChain Agentic Judge then scores every leaf dimension automatically, gathering evidence over multiple agentic rounds before judging against a per-item checklist; it reproduces the model ranking at a mean PLCC of 0.918, enough to admit new models at no annotation cost.

cs.AI

VLA-Trace: Diagnosing Vision-Language-Action Models through Representation and Behavior Tracing

Understanding how Vision-Language-Action (VLA) models transform multimodal knowledge into embodied control remains an open challenge. We present VLA-Trace, a progressive diagnostic framework that analyzes VLA models through a unified evidence chain from representation dynamics to causal control attribution and behavioral manifestation. It specifically combines cross-modal and checkpoint-drift centered kernel alignment (CKA) to trace representation evolution, attention knockout interventions to identify modality-specific control pathways, and rollout-level behavioral probes to examine grounding, shortcut dependence, and semantic following. Experiments on $π_{0.5}$ and OpenVLA reveal three key findings. First, the two models exhibit distinct modality-specific adaptation dynamics during VLA finetuning. Second, they rely on different multimodal routing strategies and layer-wise dependencies during action decoding. Third, although VLA policies excel at visually grounded trajectory generation, they remain limited in fine-grained semantic following. These findings highlight future directions for representation-preserving adaptation, causal VLA circuits, and compositional semantic control.

cs.AI

DRExplainer: Quantifiable Interpretability in Drug Response Prediction with Directed Graph Convolutional Network

Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we introduce a quantifiable method for model interpretability that leverages a ground truth benchmark dataset curated from biological features. In computational experiments, DRExplainer outperforms state-of-the-art predictive methods and another graph-based explanation method under the same experimental setting. Finally, the case studies further validate the interpretability and the effectiveness of DRExplainer in predictive novel drug response. Our code is available at: https://github.com/vshy-dream/DRExplainer.

cs.LG